Literature DB >> 24457449

Clinical significance of epithelial-mesenchymal transition-associated markers in malignant pleural mesothelioma.

Takashi Iwanami1, Hidetaka Uramoto, Makoto Nakagawa, Hidehiko Shimokawa, Sohsuke Yamada, Kimitoshi Kohno, Fumihiro Tanaka.   

Abstract

Epithelioid tumors with aggressive behavior have been reported; however, the epithelioid type of malignant pleural mesothelioma (MPM) has a less aggressive behavior. Few studies have evaluated the prognostic value of epithelial-mesenchymal transition (EMT) markers in MPM. We hypothesized that mesenchymal characteristics might predominate in the tumors. Tumor specimens were collected from 33 consecutive patients. We analyzed the EMT expression levels in tumor samples by an immunohistochemical analysis. Positive expression of E-cadherin, γ-catenin, vimentin, fibronectin, Twist and YB-1 was observed in 25, 14, 21, 1, 19 and 18 patients, respectively. No significant association between these markers and the clinicopathological characteristics was found. γ-Catenin demonstrated a trend towards decreased expression in sarcomatoid tumors compared to epithelioid tumors. On the other hand, a trend was noted towards higher expression of vimentin, Twist and YB-1 in sarcomatoid tumors. The survival curves demonstrated that the patients with negative γ-catenin and positive Twist staining had a tendency to have a worse prognosis. Although the individual proteins might not significantly affect the progression of MPM, the combination of γ-catenin and Twist staining can predict the prognosis of patients with MPM.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24457449     DOI: 10.1159/000356874

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  12 in total

1.  Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinoma.

Authors:  Y Zhang; L F Wang; J H Gao; L Li; P Jiang; X Lv; L X Yu; J Yang; R T Li; B R Liu
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

2.  Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis.

Authors:  Svenja Thies; Martina Friess; Lukas Frischknecht; Dimitri Korol; Emanuela Felley-Bosco; Rolf Stahel; Bart Vrugt; Walter Weder; Isabelle Opitz; Alex Soltermann
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

3.  Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.

Authors:  Amanda L Hudson; Chris Weir; Elizabeth Moon; Rozelle Harvie; Sonja Klebe; Stephen J Clarke; Nick Pavlakis; Viive M Howell
Journal:  Sci Rep       Date:  2014-08-21       Impact factor: 4.379

Review 4.  TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance.

Authors:  Hong Ren; Peizhun Du; Zongyu Ge; Yiting Jin; Di Ding; Xiuping Liu; Qiang Zou
Journal:  J Cancer       Date:  2016-05-25       Impact factor: 4.207

5.  Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression.

Authors:  Andrew Sulaiman; Ze-Min Yao; Li-Sheng Wang
Journal:  J Biomed Res       Date:  2018-03-26

6.  PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach.

Authors:  Marcella Barbarino; Daniele Cesari; Maria Bottaro; Luca Luzzi; Asadoor Namagerdi; Franca Maria Bertolino; Cristiana Bellan; Fabrizio Proietti; Pasquale Somma; Mariacarolina Micheli; Maria Margherita de Santi; Raffaella Guazzo; Luciano Mutti; Luigi Pirtoli; Piero Paladini; Paola Indovina; Antonio Giordano
Journal:  J Cell Mol Med       Date:  2020-04-17       Impact factor: 5.310

7.  Elevated nuclear YBX1 expression and the clinicopathological characteristics of patients with solid tumors: a meta-analysis.

Authors:  Chunze Zhang; Tingting Yin; Ran Tao; Bo Xiao; Jing Chen; Zixuan Li; Xueyuan Miao; Qing Peng; Liu Sun; Weihua Zhang; Junxu Ren; Zhao Zhang; Ying Zhang; Xichuan Li; Wei Zhang
Journal:  Cancer Manag Res       Date:  2019-05-14       Impact factor: 3.989

Review 8.  Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma.

Authors:  Thomas G Johnson; Karin Schelch; Sunali Mehta; Andrew Burgess; Glen Reid
Journal:  Front Cell Dev Biol       Date:  2019-10-01

9.  Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC/mesothelin expression.

Authors:  Masataka Kojima; Kazunori Kajino; Shuji Momose; Nadila Wali; May Thinzar Hlaing; Bo Han; Liang Yue; Masaaki Abe; Tomoaki Fujii; Katsuhisa Ikeda; Okio Hino
Journal:  Respir Res       Date:  2020-07-16

10.  Overexpression of miR-199/214 is a distinctive feature of iron-induced and asbestos-induced sarcomatoid mesothelioma in rats.

Authors:  Yasumasa Okazaki; Shan Hwu Chew; Hirotaka Nagai; Yoriko Yamashita; Hiroki Ohara; Li Jiang; Shinya Akatsuka; Takashi Takahashi; Shinya Toyokuni
Journal:  Cancer Sci       Date:  2020-05-05       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.